MOR News and Press, MorphoSys AG From 01/26/24

2024-01-26 11:18:29 ET More on MorphoSys MorphoSys: Positive Pelabresib Data Finally Unlocking Upside MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure MorphoSys climbs aft...

2024-01-19 08:38:04 ET More on pr-market losers & stocks. MorphoSys: Positive Pelabresib Data Finally Unlocking Upside MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure ...

2024-01-18 09:35:24 ET Summary Shares of biotech company MorphoSys have been climbing due to the approval chances of its lead candidate, pelabresib, for the treatment of myelofibrosis. MorphoSys co-markets and sells the drug Monjuvi in the US, which is used to treat adult patients...

2024-01-16 12:55:23 ET Gainers: Phunware ( PHUN ) +258% . DatChat ( DATS ) +61% . SEALSQ Corp ( LAES ) +40% . HomeStreet ( HMST ) +39% . Altisource Asset Management Corp ( AAMC ) +37% . Jin Medical International Ltd ( ZJYL ...

2024-01-16 10:00:59 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tu...

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 8, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PST in San Francisco, Ca...

2023-12-30 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-13 16:59:17 ET Gainers: Codexis ( CDXS ) +16% . Nubia Brand International ( NUBI ) +13% . E.W. Scripps Company  ( SSP ) +5% . WAVE Life Sciences  ( WVE ) +5% . Losers: Amtech Systems ( ASYS ) -31% . Mont...

2023-12-12 16:51:29 ET Gainers: Innovative International Acquis ( IOAC ) +24% . EF Hutton Acquisition Corporation  ( EFHT ) +5% . Denali Therapeutics  ( DNLI ) +4% . SLM Corporation ( SLM ) +4% . BioCryst Pharmaceuticals ( BC...

2023-12-11 13:57:54 ET More on MorphoSys MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure MorphoSys: Still Positive Moving Into Pelabresib Data (Maintaining Buy Rating) Mo...